SurgLine International, Inc.
SGLN · OTC
7/31/2012 | 4/30/2012 | 1/31/2012 | 10/31/2011 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.06 | 0.05 | 0.04 | -0.00 |
| FCF Yield | -1.23% | -2.32% | -2.09% | -1.46% |
| EV / EBITDA | -5.85 | -56.94 | -55.31 | -4.95 |
| Quality | ||||
| ROIC | 0.00% | 0.00% | 0.00% | 0.00% |
| Gross Margin | 231.24% | 63.52% | 21.16% | 47.62% |
| Cash Conversion Ratio | – | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | 484,241.40% | 235.12% | 219.39% | 151.48% |
| Free Cash Flow Growth | 34.07% | 68.53% | -34.97% | -324.12% |
| Safety | ||||
| Net Debt / EBITDA | -0.71 | -11.82 | -3.86 | -0.34 |
| Interest Coverage | -1.96 | -0.75 | -2.59 | -22.58 |
| Efficiency | ||||
| Inventory Turnover | 0.55 | 0.05 | 0.19 | 2.45 |
| Cash Conversion Cycle | -9,261.22 | 2,308.35 | 812.49 | 134.25 |